Back
Werewolf Therapeutics, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
23
HOWL
Werewolf Therapeutics, Inc.
Last Price:
$1.00
Seasonality Move:
29.54%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiWerewolf Therapeutics, Inc. Stock Forecast
-
Is Werewolf Therapeutics, Inc. Stock Undervalued?The current Werewolf Therapeutics, Inc. [HOWL] share price is $0.95. The Score for HOWL is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
HOWL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Werewolf Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Werewolf Therapeutics, Inc. Stock Rating
Data Unavailable
Werewolf Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
werewolftx.com
52-Week Data
52-Week High:
2.38
52-Week Low:
0.60
Prediction Charts
Market Cap:
46.2M
Price in USD:
0.95
Volume:
305.6K
Beta:
0.74
Technical Analysis
SMA50:
1.40
SMA100:
1.39
SMA200:
1.24
52-Wk Change:
-46.23%
Stock Predictions
-
Is Werewolf Therapeutics, Inc. stock public?Yes, Werewolf Therapeutics, Inc. is a publicly traded company.
-
What is the Werewolf Therapeutics, Inc. stock quote today?The Werewolf Therapeutics, Inc. stock price is 0.95 USD today.
-
How to buy Werewolf Therapeutics, Inc. stock online?You can buy Werewolf Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 0.93 | 0.92 | 1.00 | 0.92 |
| Nov-18 | 0.90 | 0.92 | 0.98 | 0.89 |
| Nov-19 | 0.98 | 0.92 | 1.00 | 0.90 |
| Nov-20 | 0.93 | 0.85 | 0.96 | 0.85 |
| Nov-21 | 0.84 | 0.87 | 0.91 | 0.80 |
| Nov-24 | 0.87 | 0.98 | 1.03 | 0.87 |
| Nov-25 | 0.99 | 0.91 | 1.00 | 0.90 |
| Nov-26 | 0.94 | 0.98 | 1.01 | 0.93 |
| Nov-28 | 0.98 | 1.00 | 1.02 | 0.97 |
| Dec-1 | 1.00 | 0.92 | 1.00 | 0.91 |
| Dec-2 | 0.90 | 0.86 | 0.95 | 0.85 |
| Dec-3 | 0.86 | 0.92 | 0.93 | 0.82 |
| Dec-4 | 0.93 | 1.00 | 1.03 | 0.92 |
| Dec-5 | 0.97 | 0.95 | 1.00 | 0.94 |
Werewolf Therapeutics, Inc. Earnings
Data Unavailable
Werewolf Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $0.25 per share.
* Werewolf Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.